Form 4: Inspire Medical Systems Director Exercises Stock Options, Increases Direct Holdings

Shawn McCormick, a Director at Inspire Medical Systems, Inc., exercised stock options to acquire 4,000 shares of common stock at $16 per share, increasing his direct beneficial ownership.

Summary

• Shawn McCormick, a Director at Inspire Medical Systems, Inc. (INSP), exercised stock options on June 4, 2025.
• He acquired 4,000 shares of common stock at an exercise price of $16 per share.
• Following this transaction, Mr. McCormick directly beneficially owns 28,046 shares of common stock.
• Additionally, 3,000 shares are indirectly owned by a trust.
• The exercised options were fully vested and exercisable, with an expiration date of May 2, 2028.
• After the exercise, Mr. McCormick still directly holds 13,296 stock options.

Sentiment

Score: 7

Explanation: The exercise of stock options by a director is generally viewed positively as it indicates confidence in the company's stock value. It's a routine transaction but the acquisition of shares adds to insider ownership, which is often seen as a good sign.

Positives

• The exercise of stock options by a director indicates confidence in the company's future prospects, as they are increasing their direct equity stake.
• The options were fully vested and exercisable, suggesting a planned transaction.

Future Outlook

This Form 4 filing is a factual report of an insider transaction and does not contain forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This Form 4 filing reports an individual insider transaction and does not provide information to analyze broader industry trends or competitor activities. Insider purchases, however, can sometimes be seen as a positive signal within the medical device industry, indicating management's belief in the company's value.

Comparison to Industry Standards

• This document reports a specific insider transaction (stock option exercise) and does not contain information that allows for a direct comparison to global benchmarks, comparable companies, projects, or results within the medical device industry. Such comparisons would typically require financial performance data, market share analysis, or product development milestones, which are not part of a Form 4 filing.

Stakeholder Impact

• Shareholders: The increase in director ownership may be perceived as a positive signal, potentially boosting investor confidence.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Next Steps

• This Form 4 filing reports a completed transaction. No specific future actions or milestones for the company are mentioned within this document.

Key Dates

Recommendation

Keywords

Inspire Medical Systems, INSP, Shawn McCormick, Stock Option Exercise, Insider Trading, Form 4, Beneficial Ownership, Director Stock Purchase, Equity Holdings